As a result, there was an overall trend for serum concentrations to decrease as body weight increased.
← all excerpts
Mirikizumab Pharmacokinetics in Patients with Moderately to Severely Active Ulcerative Colitis: Results from Phase III LUCENT Studies.
1
—
—